BUSINESS
May 13, 1998 | Reuters
A food fight between consumer groups and Procter & Gamble Co. over the labeling of snack foods made with the fat substitute olestra will go before the Food and Drug Administration next month, the agency said. The FDA will hold a public meeting to review new medical studies about complaints that olestra, an additive made by P&G, causes cramps and mild diarrhea in a small number of consumers. The fat substitute was launched in April in a variety of salty snacks.